ES / EN
- May 16, 2022 -
No Result
View All Result
OnCubaNews Needs You
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
ADVERTISEMENT
Home Cuba

Cuba: scientists involved in vaccine projects volunteer in new study

The intervention study, approved by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED), aims to evaluate the effects of vaccination in population sectors with high “risk of infection, disease and spread of the pandemic.”

by OnCuba Staff
March 23, 2021
in Cuba
0
Dr. Tays Hernández, a researcher at the Center for Molecular Immunology, participates as a volunteer in the study with Soberana 02. Photo: @centro_cim/Twitter.

Dr. Tays Hernández, a researcher at the Center for Molecular Immunology, participates as a volunteer in the study with Soberana 02. Photo: @centro_cim/Twitter.

Scientists from the Finlay Vaccine Institute and the Center for Molecular Immunology are forming part of the 150,000 volunteers in an “intervention study” with the Cuban Soberana 02 COVID-19 vaccine candidate, which began this Monday in Havana.

The new study, approved this weekend by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED), aims to evaluate the effects of vaccination in population sectors with high “risk of infection, disease and spread of the pandemic,” according to Prensa Latina (PL) news agency.

Este grupo está formado por los primeros trabajadores que se vacunarán con #Soberana02 en el marco del ensayo de intervención controlada. Ellos son investigadores, ingenieros, chóferes, abogados y personal de servicios que han apoyado el desarrollo de nuestras vacunas.#CubaViva pic.twitter.com/yd7ovFl5rN

— Instituto Finlay de Vacunas (@FinlayInstituto) March 22, 2021

Developed by the state-run Finlay Institute, Soberana 02 became the first vaccine candidate in Latin America to begin phase III of clinical trials on March 8, with 44,010 volunteers from eight municipalities in Havana.

After 15 days since the start of that trial and still without preliminary results, the new study has begun, having among its volunteers the health personnel, as well as from the pharmaceutical and biotechnological sector of the Cuban capital and other sectors defined by the Ministry of Public Health, among the which are those in charge of the development of vaccine candidates and other drugs to prevent and face COVID-19 on the island.

Inicia en el CIM proceso de vacunación de Soberana02.
Una de las primeras vacunadas es la Dra. Tays Hernández, investigadora del Centro, al frente del equipo de seguimiento de la respuesta inmune de los sujetos vacunados de las Soberanas. #VacunaCubanaCovid19 https://t.co/EV0ce87vcB pic.twitter.com/LHfkxMEVci

— Centro de Inmunología Molecular (CIM) (@centro_cim) March 22, 2021

Related Posts

Havana buildings

The Bible and politics

May 15, 2022
cuban flag and cuban soldiers. Soviet poster

The Soviets in Cuba (II)

May 14, 2022
Photo: YouTube.

Havana: gas supply enterprise confirms there have been no leaks in its production plants

May 13, 2022
Rescuers with their dogs in front of the Saratoga Hotel, in Havana, during the search and rescue work at the site. Photo: Otmaro Rodríguez.

In front of the Saratoga

May 13, 2022

The intervention will serve to demonstrate the direct and indirect consequences on the prevention of symptomatic COVID-19 and to evaluate the effect on the prevention of severe disease, as well as to assess the results of Soberana 02 on the mortality caused by the contagious disease, PL indicated.

Like the phase III trial already underway, this new study aims to document the safety profile of the vaccination scheme with two doses of this candidate and a third booster with Soberana Plus, another Cuban vaccine candidate aimed at increasing immunity against the SARS-CoV-2 in people already immunized or convalescing from the disease.

At the same time, the third phase of tests with the Abdala vaccine candidate, developed by the Center for Genetic Engineering and Biotechnology (CIGB), also began this Monday in the provinces of Santiago de Cuba, Guantánamo and Granma.

Vacuna cubana Abdala comienza su tercera fase de ensayos el próximo lunes

The necessary doses of Abdala for the study that will involve 48,000 volunteers between 19 and 80 years of age, arrived this weekend in the capitals of those eastern provinces of the island, the Agencia Cubana de Noticias news agency reported.

Cuba is going through its worst wave of coronavirus infections since the beginning of the epidemic in March of last year. With 10 of its 15 provinces and the special municipality of Isla de la Juventud in the epidemic phase and a daily average of between 700 and 900 infections, the island hopes to have a vaccine ready in the coming months to immunize its entire population this year.

Author

OnCuba Staff
Tags: coronavirus in CubaCuban scienceCuban vaccine against COVID-19
Previous Post

In the absence of bread…cassava? The bread tragedy

Next Post

Cuba surpasses 400 deaths from coronavirus

OnCuba Staff

OnCuba Staff

Next Post
Photo: Otmaro Rodríguez.

Cuba surpasses 400 deaths from coronavirus

Racial policies in Cuba

Towards a racial policy in Cuba?

Cuban Environment: mangrooves

Green Climate Fund benefits project on climate change in Cuba with financing worth millions of dollars

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

ADVERTISEMENT

Most Read

  • Gloria Estefan.

    It’s not my fault! The anguish and triumphs of Cuban music in Miami in the 1990s

    56 shares
    Share 42 Tweet 6
  • The Soviets in Cuba (II)

    6 shares
    Share 2 Tweet 2
  • Biden finally cracks the door open to Cuba

    16 shares
    Share 6 Tweet 4
  • Cuban stars in Miami

    31 shares
    Share 12 Tweet 8
  • Cuban entrepreneurs reinvent themselves to survive the pandemic

    84 shares
    Share 79 Tweet 2

Most Commented

  • The PCR test is applied at José Martí airport to travelers arriving in Cuba. The operation took between 30 and 35 seconds on average for each person seen to. Photo: Luis Carlos Gongora/Facebook/Archive.

    Cuba will charge people who travel abroad for PCR tests, at least if the country to which they are going “requires it.”

    8 shares
    Share 3 Tweet 2
  • Cuba’s position on war in Ukraine: between political realism and international law

    126 shares
    Share 50 Tweet 32
  • The “dry rice” formula

    8 shares
    Share 3 Tweet 2
  • The documentary people, between Washington and Havana

    5 shares
    Share 2 Tweet 1
  • About us
  • Work with OnCuba
  • Terms of use
  • Privacy Policy
  • Moderation policy for comments
  • Contact us
  • Advertisement offers

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

No Result
View All Result
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors

OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

Go to mobile version